Eris Gets CDSCO Panel Nod To Dapagliflozin-Bisoprolol-Sacubitril Valsartan Combo Kit, Phase IV Trial Mandated Parthika Patel23 July 2025 7:41 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...
NPPA fixes retail prices of 71 formulations including Empagliflozin, Metformin, Sitagliptin and Glimepiride Ruchika Sharma8 July 2025 5:45 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 71 formulations under Drugs (Prices Control) Order,...
Revise Phase IV Protocol for Gliclazide-Sitagliptin FDC with Scientific Justification: SEC Tells Eris Dr. Divya Colin4 Jun 2025 3:01 PM ISTNew Delhi: Reviewing the Phase IV clinical trial of Eris Lifesciences' Fixed Dose Combination (FDC) antidiabetic drug Gliclazide plus Sitagliptin, the...
Eris Lifesciences designates Gopal Agrawal, Nita Borkar in leadership roles Ruchika Sharma2 April 2025 1:16 PM ISTMumbai: Eris Lifesciences Limited, an Indian branded formulations manufacturing company, has designated Gopal Agrawal and Nita Borkar in...
Eris Lifesciences gets CDSCO Panel nod To Initiate Phase III CT of Esaxerenone Tablets Dr. Divya Colin30 March 2025 6:00 PM ISTNew Delhi: Based on the bioequivalence (BE) study of the new drug Esaxerenone Tablets 1.25, 2.5 and 5 mg, the Subject Expert Committee (SEC)...
Eris Lifesciences transfers 100% stake in 2 arms to Eris Therapeutics for Rs 861.9 crore Ruchika Sharma7 March 2025 2:30 PM ISTAhmedabad: Eris Lifesciences has announced that the Company has transferred 100 percent of its holdings in two wholly-owned subsidiaries to...
Eris Lifesciences ropes in Murari Ranganathan as President, Cardiometabolic Business Ruchika Sharma6 March 2025 12:21 PM ISTMumbai: Eris Lifesciences Limited, a Indian branded formulations manufacturing company, has appointed Murari Ranganathan as President,...
Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel Farhat Nasim4 Dec 2024 5:00 PM ISTNew Delhi: Over the last five years, six pharmaceutical suppliers have been blacklisted for providing substandard medicines to Jan Aushadhi Kendras...
Submit Source Data of Phase III CT Report: CDSCO Panel Tells Eris Lifesciences on Metoprolol Succinate plus Dapagliflozin FDC Dr. Divya Colin11 May 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial report of fixed-dose combination (FDC) drug, Metoprolol Succinate sustained released 25mg/50mg plus...
Eris Lifesciences acquires Biocon Biologics India branded formulation business for Rs 1242 crore Susmita Roy15 March 2024 1:51 PM ISTMumbai: Eris Lifesciences Ltd., a branded formulations company, has announced the acquisition of Biocon Biologics' India branded formulation...
Eris buys 51 percent stake in Swiss Parenterals for Rs 637.5 crore Ruchika Sharma14 Feb 2024 3:33 PM ISTNew Delhi: Eris Lifesciences has said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore.Ahmedabad-based Swiss Parenterals is...
Biocon Biologics to divest dermatology, nephrology branded formulations business units in India to Eris Lifesciences for Rs 366 crore Ruchika Sharma9 Nov 2023 11:45 AM ISTThe divestiture is expected to close by the end of Nov 2023, subject to customary closing conditions.
